theophylline has been researched along with Ovarian Neoplasms in 6 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epithelial ovarian cancer cells enhance their ability to migrate and invade through the epithelial-mesenchymal transition (EMT), resulting in cell seeding and metastasis in the peritoneal cavity and onto adjacent organ surfaces." | 1.39 | Epithelial-mesenchymal transition enhances nanoscale actin filament dynamics of ovarian cancer cells. ( Banaszak Holl, MM; Fishman, D; Hong, S; Lee, S; Yang, Y, 2013) |
| "Cisplatin is in common use in ovarian cancer therapy, although it is also implicated in cytotoxicity in normal tissue." | 1.31 | Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human granulosa cells transformed by a mutated p53 (p53 val135) and Ha-ras oncogene. ( Amsterdam, A; Dantes, A; Hosokawa, K; Kotsuji, F; Tajima, K; Yoshida, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L | 1 |
| Cai, S | 1 |
| Han, C | 1 |
| Banerjee, A | 1 |
| Wu, D | 1 |
| Cui, T | 1 |
| Xie, G | 1 |
| Zhang, J | 1 |
| Zhang, X | 1 |
| McLaughlin, E | 1 |
| Yin, M | 1 |
| Backes, FJ | 1 |
| Chakravarti, A | 1 |
| Zheng, Y | 1 |
| Wang, QE | 1 |
| Lee, S | 1 |
| Yang, Y | 1 |
| Fishman, D | 1 |
| Banaszak Holl, MM | 1 |
| Hong, S | 1 |
| Hirsh, L | 1 |
| Dantes, A | 2 |
| Suh, BS | 1 |
| Yoshida, Y | 2 |
| Hosokawa, K | 2 |
| Tajima, K | 2 |
| Kotsuji, F | 2 |
| Merimsky, O | 1 |
| Amsterdam, A | 2 |
| Krispin, TI | 1 |
| Parfenova, TM | 1 |
| Itkes, AV | 1 |
| Balandin, IG | 1 |
| Kuznetsov, VP | 1 |
| Severin, ES | 1 |
| Vinokurov, VL | 1 |
| Nikolaeva, LIa | 1 |
6 other studies available for theophylline and Ovarian Neoplasms
| Article | Year |
|---|---|
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Prot | 2020 |
Epithelial-mesenchymal transition enhances nanoscale actin filament dynamics of ovarian cancer cells.
Topics: Actin Cytoskeleton; Actins; Cell Line, Tumor; Cell Movement; Drug Combinations; Epithelial-Mesenchym | 2013 |
Phosphodiesterase inhibitors as anti-cancer drugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Drug Synergism; Female; Humans; Lung Neopl | 2004 |
Antiviral activity of lambda-, beta-, and gamma-interferons in the presence of theophylline: involvement of 2',5'-oligo(A) synthetase.
Topics: 2',5'-Oligoadenylate Synthetase; Cell Line; Cyclic AMP; Encephalomyocarditis virus; Female; Humans; | 1984 |
Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human granulosa cells transformed by a mutated p53 (p53 val135) and Ha-ras oncogene.
Topics: Antineoplastic Agents; Apoptosis; Cisplatin; Drug Therapy, Combination; Female; Genes, ras; Granulos | 2000 |
[Cellular immunity indices of ovarian cancer patients].
Topics: Female; Humans; Immunity, Cellular; Leukocyte Count; Neoplasm Recurrence, Local; Ovarian Neoplasms; | 1986 |